Institutional Analysis of Non-metastatic Pancreatic Adenocarcinoma Outcomes from 2011-2016


About this study

The purpose of this study is to evaluate survival of patients with resectable, borderline resectable pancreatic cancer (BRPC) and locally advanced pancreatic cancer (LAPC) separately and as a group.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Amit Mahipal, M.B.B.S.

Closed for enrollment

Contact information:

Amit Mahipal M.B.B.S.

(507) 293-0487

More information


Publications are currently not available

Mayo Clinic Footer